Illumina Drops Below $51 Offer on Concern Roche Will Walk

Illumina Inc., which has twice rejected unsolicited takeover bids from Roche Holding AG, fell below the $51-a-share current offer as investors grew concerned that the Swiss drugmaker would abandon the deal.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.